Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis

Mediators Inflamm. 2005 Dec 14;2005(6):390-4. doi: 10.1155/MI.2005.390.

Abstract

The aim of the present study was to evaluate the effects of N-acetylcysteine (NAC) and L-carnitine (LCAR) supplementations on polymorphonuclear leukocytes myeloperoxidase (MPO) and Cu/Zn-superoxide dismutase (Cu/Zn-SOD) and plasma malondialdehyde (MDA) in acetic acid (AA)-induced ulcerative colitis model. The mean polymorphonuclear leukocyte MPO and Cu/Zn-SOD activity was significantly higher in the colitis group than in the control group. Both NAC and LCAR pretreatment markedly decreased MPO and Cu/Zn-SOD activity compared to colitis group. AA administration significantly increased the levels of plasma MDA in comparison with controls. However, NAC and LCAR administration to the AA-treated rats significantly reduced the MDA levels compared to colitis group. In conclusion NAC and LCAR could be beneficial agents in restoring the circulating proinflammatory mediators.

MeSH terms

  • Acetylcysteine / therapeutic use*
  • Animals
  • Antioxidants / therapeutic use
  • Carnitine / therapeutic use*
  • Colitis, Ulcerative* / blood
  • Colitis, Ulcerative* / drug therapy
  • Colitis, Ulcerative* / enzymology
  • Free Radical Scavengers / therapeutic use
  • Leukocytes / enzymology*
  • Male
  • Malondialdehyde / blood*
  • Peroxidase / metabolism*
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase / metabolism*
  • Vitamin B Complex / therapeutic use

Substances

  • Antioxidants
  • Free Radical Scavengers
  • Vitamin B Complex
  • Malondialdehyde
  • Peroxidase
  • Superoxide Dismutase
  • Carnitine
  • Acetylcysteine